Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 4171 AL 4185

Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease

Choi H, Koh SH.

Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):83-90. doi: 10.1080/17425255.2018.1417387. Epub 2017 Dec 15.

iPS cells in the study of PD molecular pathogenesis

Cobb MM, Ravisankar A, Skibinski G, Finkbeiner S.

Cell Tissue Res. 2018 Jul;373(1):61-77. doi: 10.1007/s00441-017-2749-y. Epub 2017 Dec 12.

Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis

Mills KA, Greene MC, Dezube R, Goodson C, Karmarkar T, Pontone GM.

Int J Geriatr Psychiatry. 2018 Apr;33(4):642-651. doi: 10.1002/gps.4834. Epub 2017 Dec 13.

Modeling Parkinson's disease and treatment complications in rodents: Potentials and pitfalls of the current options

Francardo V.

Behav Brain Res. 2018 Oct 15;352:142-150. doi: 10.1016/j.bbr.2017.12.014. Epub 2017 Dec 10.

Kinases in synaptic development and neurological diseases

Baltussen LL, Rosianu F, Ultanir SK.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt B):343-352. doi: 10.1016/j.pnpbp.2017.12.006. Epub 2017 Dec 11.

Animal models of L-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse

Tronci E, Francardo V.

J Neural Transm (Vienna). 2018 Aug;125(8):1137-1144. doi: 10.1007/s00702-017-1825-5. Epub 2017 Dec 14.

Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia

Trunfio M, Joseph SB, Ghisetti V, Romito A, Martini C, Cusato J, Audagnotto S, Pesci Kincer L, Ferrara M, Sala A, Imperiale D, Di Perri G, Calcagno A.

J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.

Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data

Ypinga JHL, de Vries NM, Boonen LHHM, Koolman X, Munneke M, Zwinderman AH, Bloem BR.

Lancet Neurol. 2018 Feb;17(2):153-161. doi: 10.1016/S1474-4422(17)30406-4. Epub 2017 Dec 12.

Leptin and ghrelin: Sewing metabolism onto neurodegeneration

de Candia P, Matarese G.

Neuropharmacology. 2018 Jul 1;136(Pt B):307-316. doi: 10.1016/j.neuropharm.2017.12.025. Epub 2017 Dec 15.

The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study

Valldeoriola F, Salvador A, Gómez-Arguelles JM, Marey J, Moya M, Ayuga Á, Ramírez F.

Int J Neurosci. 2018 Apr;128(4):369-375. doi: 10.1080/00207454.2017.1387111. Epub 2017 Dec 17.

Deep brain stimulation for lesion-related tremors: A systematic review and meta-analysis

Mendonça MD, Meira B, Fernandes M, Barbosa R, Bugalho P.

Parkinsonism Relat Disord. 2018 Feb;47:8-14. doi: 10.1016/j.parkreldis.2017.12.014. Epub 2017 Dec 13.

Before and after the veterans affairs cooperative program 468 study: Deep brain stimulator target selection for treatment of Parkinson's disease

Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS.

Parkinsonism Relat Disord. 2018 Mar;48:40-44. doi: 10.1016/j.parkreldis.2017.12.013. Epub 2017 Dec 12.

Sex differences in sleep apnea and comorbid neurodegenerative diseases

Snyder B, Cunningham RL.

Steroids. 2018 May;133:28-33. doi: 10.1016/j.steroids.2017.12.006. Epub 2017 Dec 16.

Technical Note: Preemptive Surgical Revision of Impending Deep Brain Stimulation Hardware Erosion

Barrett TF, Rasouli JJ, Taub P, Kopell BH.

World Neurosurg. 2018 Mar;111:41-46. doi: 10.1016/j.wneu.2017.12.045. Epub 2017 Dec 16.

Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer

Silva JL, Cino EA, Soares IN, Ferreira VF, A P de Oliveira G.

Acc Chem Res. 2018 Jan 16;51(1):181-190. doi: 10.1021/acs.accounts.7b00473. Epub 2017 Dec 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias